Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M122Revenue $M111Net Margin (%)-95.8Altman Z-Score-3.2
Enterprise Value $M79.7EPS $-1.0Operating Margin %-66.2Piotroski F-Score1
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-96.0Higher ROA y-yN
Price/Book5.910-y EBITDA Growth Rate %--Quick Ratio4.6Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %1.8Current Ratio4.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-133.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M104ROIC % (ttm)-991.9Gross Margin Increase y-yN

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
VVUSFirst Eagle Investment 2013-06-30 Sold Out -0.01%$10.43 - $15.1
$ 1.13-91%Sold Out0
VVUSFirst Eagle Investment 2013-03-31 Buy 0.01%$10.2 - $14.87
$ 1.13-91%New holding200,000
VVUSGeorge Soros 2012-09-30 Sold Out -0.06%$17.81 - $29.93
$ 1.13-95%Sold Out0
VVUSGeorge Soros 2012-06-30 Reduce-0.09%$21.5 - $28.68
$ 1.13-95%Reduce 64.93%150,000
VVUSGeorge Soros 2012-03-31 Buy 0.14%$9.99 - $23.78
$ 1.13-92%New holding427,750
VVUSGeorge Soros 2011-03-31 Sold Out $6.06 - $11.2
$ 1.13-86%Sold Out0
VVUSGeorge Soros 2010-12-31 Buy $5.94 - $9.78
$ 1.13-85%New holding19,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VVUS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Varghese Santosh TVP, Medical & Reg Affairs 2015-07-01Sell7,899$2.32-51.29 view
Slebir John LSVP, Business Development & GC 2015-07-01Sell9,215$2.32-51.29 view
Day WesleyVP, Clinical Development 2015-07-01Sell7,881$2.32-51.29 view
Day WesleyVP, Clinical Development 2015-01-29Sell472$2.78-59.35 view
Slebir John LSVP, Business Development & GC 2015-01-29Sell630$2.78-59.35 view
MARSH GUY PVP, US Operations & GM 2015-01-29Sell238$2.78-59.35 view
Sanford Svai SCFO & Chief Accounting Officer 2015-01-29Sell472$2.78-59.35 view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-08Buy500,000$3.12-63.78 view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-06Buy476,800$3.04-62.83 view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-02Buy523,200$2.9-61.03 view

Quarterly/Annual Reports about VVUS:

    News about VVUS:

    Articles On GuruFocus.com
    Biotech Momentum Indicators: Achaogen (AKAO), Novartis (NVS), VIVUS (VVUS) Apr 01 2015 
    5-year lows: PICO Holdings Inc, Black Box Corp, Vivus, and Electro Rent Corp. Mar 29 2015 
    A Look at Pharma Company Dermira's Performance Mar 27 2015 
    5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
    Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
    Unique Investor Kyle Bass Unloads Five May 29 2013 
    Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
    Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 

    More From Other Websites
    Why VIVUS (VVUS) Could Shock the Market Soon Aug 31 2015
    VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 18 2015
    Stocks Trading Near Their 52-Week Lows: 4 Hot Picks Aug 14 2015
    VIVUS Inc. (VVUS) in Focus: Stock Jumps 5.4% Aug 13 2015
    VIVUS (VVUS) Is in Oversold Territory: What's Next? Aug 13 2015
    VIVUS INC Financials Aug 06 2015
    The Zacks Analyst Blog Highlights: Amgen, Vertex, Regeneron, Baxalta and VIVUS - Press Releases Aug 06 2015
    VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events Aug 06 2015
    10-Q for VIVUS, Inc. Aug 05 2015
    VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 05 2015
    Biotech Stock Roundup: Baxalta Rejects Shire Bid, Amgen's Beat & Raise Quarter - Analyst Blog Aug 05 2015
    VIVUS INC Files SEC form 10-Q, Quarterly Report Aug 03 2015
    Bay Area obesity drug maker slims down as market slows Jul 31 2015
    Express Scripts excludes 20 more drugs from 2016 coverage Jul 31 2015
    Edited Transcript of VVUS earnings conference call or presentation 30-Jul-15 8:30pm GMT Jul 31 2015
    Vivus (VVUS) Stock Falls Following Earnings Release, Restructuring Plan Jul 31 2015
    VIVUS (VVUS) Q2 Loss Narrower, Restructuring Announced - Analyst Blog Jul 31 2015
    Vivus reports 2Q loss Jul 30 2015
    Vivus reports 2Q loss Jul 30 2015
    VIVUS Inc Earnings Call scheduled for 4:30 pm ET today Jul 30 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)